Internal Medicine, Rheumatology · Philadelphia, PA
NPI
1346211844
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
6
Hospital affiliations
822 Pine St, Ste 3a
Philadelphia, PA, 19107
Phone (215) 829-5358
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.5M
111,899 services
Medicare patients, 2024
596
Average age 76
Drug cost, 2024
$2.1M
4,247 prescriptions
Company payments, 2025
$48K
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alan L Epstein was code J1602 (injection, golimumab, 1 mg, for intravenous use), 19,800 times for 26 patients. In total Alan L Epstein billed 111,899 services in 40 codes, and Medicare paid $1.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-06-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 19,800 | 26 | $9.07 | $180K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 16,800 | 15 | $8.57 | $144K |
| J0897 Injection, denosumab, 1 mg | Office | 15,060 | 149 | $20.53 | $309K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 2,900 | 47 | $0.10 | $295 |
| 99214 Office E&M - Established | Office | 1,155 | 529 | $99.32 | $115K |
| 36415 Venipuncture Blood Collection | Office | 514 | 285 | $8.65 | $4,446 |
| 96372 Injection Administration | Office | 423 | 161 | $12.66 | $5,354 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 414 | 273 | $13.59 | $5,628 |
| 96413 Chemotherapy Administration | Office | 281 | 46 | $114.74 | $32K |
| J3489 Injection, zoledronic acid, 1 mg | Office | 120 | 23 | $5.16 | $619 |
| 96365 Intravenous Infusion, Hydration | Office | 114 | 33 | $55.74 | $6,354 |
| 99204 Office E&M - New | Office | 79 | 79 | $129.96 | $10K |
| 20610 Joint Injection | Office | 62 | 47 | $57.17 | $3,544 |
| J1030 Injection, methylprednisolone acetate, 40 mg | Office | 31 | 26 | $3.62 | $112 |
| 99215 Office E&M - Established | Office | 30 | 27 | $142.23 | $4,267 |
By year: 2022 $943K for 61,794 services; 2023 $1.1M for 75,012 services; 2024 $1.5M for 111,899 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 514 | 285 | $8.65 | $4,446 |
| 85810 Clinical Chemistry | 28 | 15 | $11.44 | $320 |
| 89050 Blood Count | 24 | 13 | $4.63 | $111 |
Medicare prescription drug claims, 2024
In 2024, the drug Alan L Epstein prescribed most often to Medicare patients was Prednisone, with 588 prescriptions and refills. In total Alan L Epstein wrote 4,247 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 588 | 805 | 174 | $4,077 |
| Meloxicam Generic | 504 | 707 | 117 | $1,397 |
| Tramadol Hcl Generic | 339 | 357 | 66 | $1,859 |
| Methotrexate Methotrexate Sodium | 217 | 415 | 50 | $4,252 |
| Gabapentin Generic | 169 | 288 | 41 | $2,733 |
| Hydroxychloroquine Sulfate Generic | 157 | 289 | 35 | $3,340 |
| Allopurinol Generic | 149 | 306 | 29 | $1,403 |
| Pregabalin Generic | 145 | 183 | 28 | $2,782 |
| Duloxetine Hcl Generic | 136 | 240 | 38 | $3,500 |
| Alendronate Sodium Generic | 117 | 282 | 34 | $937 |
| Tramadol Hcl-Acetaminophen Tramadol Hcl/Acetaminophen | 114 | 118 | 17 | $2,328 |
| Zolpidem Tartrate Generic | 85 | 103 | 15 | $516 |
| Celecoxib Generic | 78 | 108 | 22 | $1,478 |
| Sulfasalazine Generic | 76 | 104 | 16 | $1,803 |
| Leflunomide Generic | 74 | 168 | 18 | $3,698 |
Brand drugs: - claims; generic drugs: 3,854 claims; opioid claims: 613.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alan L Epstein $48K ($48K in general payments such as food, travel and fees) from 10 companies. The largest payer was Janssen Biotech, Inc. with $16K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 14 | $16K |
| GlaxoSmithKline, LLC. GSK | 3 | $11K |
| Abbvie Inc. ABBV | 16 | $7,478 |
| AstraZeneca Pharmaceuticals LP AZN | 12 | $3,813 |
| Sobi, Inc SOBI.ST | 4 | $2,810 |
| Janssen Scientific Affairs, LLC JNJ | 1 | $2,565 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $2,073 |
| Invivyd Inc IVVD | 1 | $2,013 |
| Amgen Inc. AMGN | 14 | $379 |
| Pfizer Inc. PFE | 1 | $18.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.